Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,381.00
-102.00 (-4.11%)
May 29, 2026, 3:30 PM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,907. The average 1-year stock price forecast is 22.10% higher than the current stock price, while the lowest is ¥2,500 (+5.00%) and the highest is ¥3,400 (+42.80%).
Price Target: ¥2,907 (+22.10%)
Analyst Consensus: Buy
* Price targets were last updated on Dec 24, 2025.
Analyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Upgrades ¥2,980 | Buy | Upgrades | ¥2,980 | +25.16% | Dec 24, 2025 |
Unknown Analyst UBS No rating | UBS | Hold Initiates ¥2,600 | Hold | Initiates | ¥2,600 | +9.20% | Dec 12, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.